Pharmaceuticals

Global Mass Spectrometry Imaging Market Size and Forecast to 2029: Revenue, Growth, and Trends

December 4, 2025 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the mass spectrometry imaging market from 2025–2034 with trusted insights from The Business Research Company

How Big Is The Mass Spectrometry Imaging Market Size Today And What Will Its Value Be At The End Of 2029?

The mass spectrometry imaging market has experienced robust expansion over recent years. It is projected to expand from $2.65 billion in 2024 to $2.88 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 8.8%. The growth observed in prior periods is attributable to factors such as increasing adoption in pharmaceutical research, rising demand for personalized medicine, a rise in cancer diagnostics applications, an increase in drug discovery and development activities, and increasing funding for biomedical research.

The mass spectrometry imaging market is projected to experience substantial expansion over the upcoming years. This market is predicted to reach “$4.07 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 9.0%. Factors driving this expansion during the forecast period include an escalating emphasis on spatial omics research, increased adoption in biomarker identification, greater integration with artificial intelligence tools, broader applications in clinical diagnosis, and a heightened need for high-resolution imaging methods. Key trends anticipated during this period encompass enhancements in high-resolution mass spectrometry technologies, sophisticated imaging software integration, novel sample preparation techniques, progress in hybrid imaging modalities, and enhanced automation within data analysis workflows.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24288&type=smp

Which Key Drivers Are Powering Growth In The Mass Spectrometry Imaging Market?

The increasing demand for personalized medicine is projected to drive the expansion of the mass spectrometry imaging market in the future. This approach involves tailoring healthcare treatments for individual patients, taking into account their genetic composition, surroundings, and daily habits to enhance efficacy. Genomic progress underpins the growth of personalized medicine, facilitating targeted therapies that leverage genetic profiles to boost effectiveness and mitigate adverse reactions. Mass spectrometry imaging aids personalized medicine through the generation of intricate molecular maps of tissues, assisting in the identification of disease biomarkers, and enabling the creation of targeted therapies specifically designed for individual patient profiles. For example, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, reported that the FDA sanctioned 16 novel personalized treatments for patients with rare diseases in 2023, representing a notable rise from the six approved in 2022. Consequently, the increasing need for personalized medicine is propelling the expansion of the mass spectrometry imaging market.

Which Segment Categories Are Driving Maximum Growth In The Mass Spectrometry Imaging Market?

The mass spectrometry imaging market covered in this report is segmented –

1) By Product Type: Instruments, Consumables, Services

2) By Technology: Matrix-Assisted Laser Desorption Or Ionization (MALDI), Secondary Ion Mass Spectrometry (SIMS), Desorption Electrospray Ionization (DESI), Magnetic Sector Mass Spectrometry, Time-of-Flight Mass Spectrometry (TOFMS), Other Technologies

3) By Application: Proteomics, Metabolomics, Glycomics, Other Applications

4) By End-User: Pharmaceutical and Biotechnology Companies, Government and Academic Institutions, Other End-Users

Subsegments:

1) By Instruments: High-Resolution Mass Spectrometers, Imaging Mass Spectrometers, Matrix-Assisted Laser Desorption Or Ionization Time-of-Flight System, Liquid Chromatography-Mass Spectrometry System, Quadrupole Time-of-Flight Mass Spectrometers, Tandem Mass Spectrometers

2) By Consumables: Reagents And Chemicals, Sample Preparation Kits, Mass Spectrometry Plates And Slides, Calibration Standards, Solvents And Buffers

3) By Services: Installation And Maintenance Services, Data Analysis And Software Services, Training And Support Services, Consultation And Customization Services

What Key Trends Are Driving Growth In The Mass Spectrometry Imaging Market?

Major companies operating in the mass spectrometry imaging (MSI) market are focusing on developing advanced technologies, such as desorption electrospray ionization, to enable more accurate and detailed molecular analysis for a wide range of applications. Desorption electrospray ionization (DESI) is an ionization method that extracts ions from surfaces in ambient conditions utilizing a charged solvent spray. It facilitates direct analysis of solid samples, like tissues, without requiring sample preparation or extraction. For instance, in June 2023, Waters Corporation, a US-based analytical laboratory instrument manufacturing company, introduced a targeted imaging mass spectrometer. This instrument improves tissue analysis with enhanced sensitivity and faster operation. It delivers more precise small-molecule drug analysis, providing higher resolution in targeted imaging. The technology allows for quicker detection, thereby streamlining biological studies. This device boosts accuracy and efficiency, offering significant benefits to research processes. This innovation supports advanced drug development and biological research by furnishing detailed, high-quality data.

Who Are The Leading Companies Driving The Mass Spectrometry Imaging Market?

Major companies operating in the mass spectrometry imaging market are Thermo Fisher Scientific Inc., Danaher Corporation, Hitachi High-Tech Corporation, Shimadzu Corporation, Waters Corporation, Bruker Corporation, Horiba Scientific, JEOL Ltd., SCIEX, Analytik Jena AG, Standard BioTools, TOFWERK AG, Advion Inc., MassTech Inc., CovalX AG, ImaBiotech SAS, MassAnalytica LLC, Ionwerks Inc., Biognosys AG, Spectroswiss Sàrl

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/mass-spectrometry-imaging-global-market-report

Which Region Holds The Largest Share In The Mass Spectrometry Imaging Market Today?

North America was the largest region in the mass spectrometry imaging market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mass spectrometry imaging market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=24288&type=smp

Browse Through More Reports Similar to the Global Mass Spectrometry Imaging Market 2025, By The Business Research Company

Mass Spectrometry Market 2025

https://www.thebusinessresearchcompany.com/report/mass-spectrometry-market

Mass Spectrometry Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/mass-spectrometry-global-market-report

3D Diagnostic Imaging Services Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/3d-diagnostic-imaging-services-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795